C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2011
10/13/2011	CA2789818A1 Inverse agonists and neutral antagonists for the tsh receptor
10/12/2011	EP2374801A1 Method for producing quinazoline derivative
10/12/2011	CN102216316A Substituted amine derivative and medicinal composition comprising same as the active ingredient
10/12/2011	CN102216273A Naphthylacetic acids used as crth2 antagonists or partial agonists
10/12/2011	CN101421252B 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
10/12/2011	CN101258134B 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
10/12/2011	CN101175734B Quinazoline derivatives as antineoplastic medicine and its production method
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034932 Hydroxy-3-methylglutaryl/3-/ coenzyme A reductase inhibitor; anticholesterol agents;dyslipidemia; chemical intermediate for rosuvastatin
10/11/2011	US8034931 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
10/11/2011	US8034824 Iontophoretic preparation for treatment of breast cancer and/or mastitis
10/11/2011	US8034822 Glucokinase activators
10/11/2011	US8033981 Radioactive member and method of making
10/11/2011	CA2471436C Non-sedating barbituric acid derivatives
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011121598A1 Crystalline 7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3(r)-hydroxy-5-oxo-hept-6-enoic acid methyl ester and process thereof
10/06/2011	WO2011121595A1 A process for the preparation of rosuvastatin calcium
10/06/2011	WO2011120626A1 Materials for organic electroluminescence devices
10/06/2011	WO2011120153A1 Compounds and method for treatment of hiv
10/06/2011	WO2010104406A8 Prodrug forms of kinase inhibitors and their use in therapy
10/06/2011	US20110245458 Peptide nucleic acid monomers and oligomers
10/06/2011	US20110245284 Alkoxy- and Alkylthio-Substituted Anilinopyrimidines
10/06/2011	US20110245282 Compounds
10/06/2011	US20110245249 Heterocyclically Substituted Anilinopyrimidines
10/06/2011	US20110245242 Heterocyclically Substituted Anilinopyrimides
10/06/2011	US20110245156 Novel antiviral compounds, compositions, and methods of use
10/06/2011	US20110244486 Methods and compositions for the diagnosis and treatment of diabetes
10/06/2011	DE102010013806A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
10/05/2011	EP2371822A1 Heterobicyclic carboxamides as inhibitors for kinases
10/05/2011	EP2370417A2 Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
10/05/2011	EP2370416A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
10/05/2011	EP2370415A2 Compositions and methods for inhibition of the jak pathway
10/05/2011	EP2370414A2 Preparation of capecitabine
10/05/2011	EP2370411A2 Compounds having antiparasitic or anti-infectious activity
10/05/2011	EP1858520B1 Quinazolinone t-type calcium channel antagonists
10/05/2011	EP1575940B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/05/2011	CN1938285B 4-anilinequinazolines with adenosine-kiase inhibitor properties
10/05/2011	CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity
10/05/2011	CN1817883B New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
10/05/2011	CN102206207A 4-aryl pyrimidine or 4-heterocyclic aryl pyrimidine compound luminescent material and preparation method thereof
10/05/2011	CN102206187A New synthetic method for 6-benzyl-1-ethoxymethyl-5-isopropyluracil (Emivirine) and its analogues
10/05/2011	CN102206172A Substituted diaryl compound and preparation method and antiviral application thereof
10/04/2011	US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011	US8030488 Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
10/04/2011	US8030487 2-amino—5-substituted pyrimidine inhibitors
10/04/2011	US8030483 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/04/2011	US8030321 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
10/04/2011	US8030304 Thiazole pyrazolopyrimidines CRF1 receptor antagonists
10/04/2011	CA2510528C Biphenyl derivatives and their use as fungicides
10/04/2011	CA2509344C Process for the preparation of pyrimidine compounds
10/04/2011	CA2491079C Therapeutic piperazine derivatives useful for treating pain
09/2011
09/29/2011	WO2011118672A1 Plasma kallikrein inhibitor
09/29/2011	WO2011117143A1 Process for the preparation of bosentan
09/29/2011	WO2011116933A1 Process for the preparation of 2-substituted 4-amino-5-cyanopyrimidines
09/29/2011	WO2011116634A1 Process and intermediates for preparing lapatinib
09/29/2011	WO2011056957A3 Enzyme inhibiting compounds
09/29/2011	US20110237793 Process for preparing antiviral compound
09/29/2011	US20110237612 Thienylamino pyrimidines for use as Fungicides
09/29/2011	US20110237598 New compounds
09/29/2011	US20110237595 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
09/29/2011	US20110237576 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having bace1-inhibiting activity
09/29/2011	US20110233463 Chiral compounds, cholesteric and ferroelectric liquid crystal compositions comprising these chiral compounds, and liquid crystal displays comprising these liquid crystal compositions
09/29/2011	CA2793742A1 Process and intermediates for preparing lapatinib
09/28/2011	EP2368884A1 Process for the preparation of bosentan
09/28/2011	EP2368883A1 Process for the preparation of 2-substituted 4-amino-5-cyanopyrimidines
09/28/2011	EP2368882A1 Anti-infective pyrimidines and uses thereof
09/28/2011	EP2367801A1 Polar quinazolines as liver x receptors ( lxrs ) modulators
09/28/2011	EP2367800A2 New compounds
09/28/2011	EP2367799A1 New compounds
09/28/2011	EP1966161B1 Carboxamides for controlling undesired micro-organisms in plant protection
09/28/2011	CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011	CN102203087A Heterocyclically substituted anilinopyrimidines as fungicides
09/28/2011	CN102203071A Uracil-based compounds, and herbicides comprising same
09/28/2011	CN102203070A Alkoxy-substituted and alkylthio-substituted anilinopyrimidines
09/28/2011	CN102203069A Process for the preparation of substituted phenylalanines
09/28/2011	CN102203064A Novel benzamides, production thereof, and use thereof as medicaments
09/28/2011	CN102199127A Method for preparing azoxystrobin
09/28/2011	CN101723906B Compound, medical composition containing same as well as preparation method and application
09/28/2011	CN101704790B Phytocidal N-uracil-substituted phenyl aryloxy-alkyl amide compound
09/27/2011	US8026362 Non-nucleoside reverse transcriptase inhibitors
09/27/2011	US8026248 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide combined with another retrovirus inhibitor; viricides; treatment of AIDS
09/27/2011	US8026247 Bicyclic amides as kinase inhibitors
09/27/2011	US8026243 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors
09/27/2011	US8026057 Nucleic acid labeling compounds
09/27/2011	CA2467683C 5-phenylpyrimidines, agents comprising the same, method for production and use thereof
09/27/2011	CA2457410C Compounds effecting glucokinase
09/22/2011	WO2011115183A1 Novel monocyclic pyrimidine derivative
09/22/2011	WO2011114338A1 A process for the preparation of highly pure ambrisentan
09/22/2011	WO2011114163A1 Substituted quinazolines (open ring)
09/22/2011	WO2011114103A1 Pyrimidinones for use as medicaments
09/22/2011	WO2011113512A1 Morpholinylquinazolines
09/22/2011	WO2011113309A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
09/22/2011	US20110230505 Quinazoline inhibitors of bace 1 and methods of using
09/22/2011	US20110230494 Heteroaryl compounds and uses thereof
09/22/2011	US20110230488 Hybrid-ionone and curcumin molecules as anticancer agents
09/22/2011	US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors
09/22/2011	US20110230478 4-Alkyl-substituted diaminopyrimidines
09/22/2011	US20110230465 Viral polymerase inhibitors
09/22/2011	US20110230446 Cathepsin cysteine protease inhibitors
09/22/2011	US20110229918 Method of Quantifying Transient Interactions Between Proteins

1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 427